Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
86.3M
-
Number of holders
-
64
-
Total 13F shares, excl. options
-
21.4M
-
Shares change
-
+21.4M
-
Total reported value, excl. options
-
$718M
-
Value change
-
+$718M
-
Number of buys
-
64
-
Price
-
$33.73
Significant Holders of Oric Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (ORIC) as of Q2 2020
64 filings reported holding ORIC - Oric Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share as of Q2 2020.
Oric Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (ORIC) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.4M shares
of 86.3M outstanding shares and own 24.78% of the company stock.
Largest 10 shareholders include Svennilson Peter (4.77M shares), FMR LLC (4.21M shares), ORBIMED ADVISORS LLC (2.92M shares), EcoR1 Capital, LLC (2.64M shares), Invus Financial Advisors, LLC (1.01M shares), BlackRock Inc. (869K shares), WELLS FARGO & COMPANY/MN (571K shares), VICTORY CAPITAL MANAGEMENT INC (568K shares), Foresite Capital Management III, LLC (497K shares), and VANGUARD GROUP INC (429K shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.